Abstract
The dose dependency in the hepatic transport of an anionic fluorescent dye, 1-anilino-8-naphthalene sulfonate (ANS), was investigated by measuring the plasma disappearance and biliary excretion in rats. Bulk of the administered ANS distributed into the liver at 10 min after iv bolus injection. The plasma disappearance curves of ANS were then kinetically analyzed based on a two-compartment model, in which the ligand is eliminated only from the peripheral compartment (liver compartment). The total body clearance (CLtot) decreased with increasing dose of ANS. That is, the values of CLtot were 4.06 and 1.98 ml/min/per kg at the doses of 3 and 100 Μmol/kg, respectively. The clearances of the uptake and sequestration processes (CLup and CLseq, respectively) for a total ligand were constant irrespective of dose, while the efflux clearance (CLeff) for a total ligand was increased by twofold with increasing dose. A mechanism for the increase in the CLeff value might be explained by a saturation of the ANS binding to the intracellular proteins. The hepatocellular distribution and the binding of ANS to cytosolic proteins were then determined. ANS mainly distributed to the cytosol fraction, and the unbound fraction in the cytosol increased from approximately 0.04 to 0.09 when the cytosolic concentrations of ANS increased from 40 to 900 ΜM, respectively. In,spite of such increase in the unbound fraction in the cytosol, the CLseq values remained unchanged with increasing dose, suggesting that the saturation of sequestration clearance for unbound ANS might occur. Furthermore, the plasma disappearance curves of ANS at various doses were simultaneously analyzed based on three nonlinear kinetic models: Model I is a model incorporating both saturable intracellular binding and saturable sequestration; Model II is a model incorporating only saturable intracellular binding; Model III is the model incorporating only saturable sequestration. Goodness- of- fit evaluated by AIC value was best for Model I. Taken together, the nonlinearity in the plasma clearance of ANS was confirmed to be attributed to saturation of both its binding to cytosolic proteins and sequestration process.
Similar content being viewed by others
References
B. F. Scharschmidt, J. G. Waggoner, and P. D. Berk. Hepatic organic anion uptake in the rat.J. Clin. Invest. 56:1280–1292 (1975).
C. A. Goresky. Initial distribution and rate of uptake of sulfobromophthalein in the liver.Am. J. Physiol. 207:13–26 (1964).
J.-C. Glasinovic, M. Dumont, M. Duval, and S. Erlinger. Hepatocellular uptake of taurocholate in the dog.J. Clin. Invest. 55:419–426 (1975).
T. Iga and C. D. Klaassen. Hepatic extraction of nonmetabolizable xenobiotics in rats.J. Pharmacol. Exp. Ther. 211:690–697 (1979).
G. Paumgartner and J. Reichen. Different pathways for hepatic uptake of taurocholate and indocyanine green.Experientia (Basel).32:306–308 (1975).
G. Paumgartner and J. Reichen. Kinetics of hepatic uptake unconjugated bilirubin.Clin. Sci. Mol. Med. 51:169–176 (1976).
J. Reichen and G. Paumgartner. Uptake of bile acids by perfused rat liver.Am. J. Physiol. 231:734–742 (1976).
D. K. F. Meijer, R. J. Vonk, K. Keulemans, and J. G. Weitering. Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of Y and Z protein.J. Pharmacol. Exp. Ther. 202:8–21 (1977).
U. Gartner, R. J. Stocken, W. G. Levine, and A. W. Wolkoff. Effect of Nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver.Gastroenterology 83:1163–1169 (1982).
L. Schwarz, R. Burr, M. Schwenk, E. Pfaff, and H. Greim. Uptake of taurocholic acid into isolate rat-liver cells.Eur. J. Biochem. 55:617–623 (1975).
M. Schwenk, R. Burr, L. Schwarz, and E. Pfaff. Uptake of bromosulfophthalein by isolated liver cells.Eur. J. Biochem. 64:189–197 (1976).
M. S. Anwer, R. Korker, and D. Hegner. Cholic acid uptake into isolated hepatocytes.Hoppe-Seyler's Z. Physiol. Chem. 357:1477–1486 (1976).
S. C. Tsao, Y. Sugiyama, K. Shinmera, Y. Sawada, S. Nagase, T. Iga, and M. Hanano. Protein-mediated hepatic uptake of rose bengal in analbuminemic mutant rats (NAR).Drug Metab. Dispos. 16:482–489 (1988).
Y. Sugiyama, S. Kimura, J. H. Lin, M. Izukura, S. Awazu, and M. Hanano. Effects of organic anions on the uptake of 1-anilino-8-naphthalene sulfonate by isolated liver cells.J. Pharm. Sci. 72:871–876 (1983).
P. D. Berk, B. J. Potter, and W. Stremmel. Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions.Hepatology 7:165–176 (1987).
R. Weisiger, J. Gollan, and R. K. Ockner. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.Science 211:1048–1051 (1981).
R. K. Ockner, R. A. Weiseger, and J. L. Gollan. Hepatic uptake of albumin-bound substances: The albumin receptor concept.Am. J. Physiol. 245:613–618 (1983).
E. L. Forker and B. A. Luxon. Albumin helps mediate removal of taurocholate by rat liver.J. Clin. Invest. 67:1517–1522 (1981).
E. L. Forker and B. A. Luxon. Hepatic transport and binding of rose bengal in the presence of albumin and gamma globulin.Am. J. Physiol. 248:G702-G708 (1985).
E. L. Forker and B. A. Luxon. Effects of unstirred disse fluid, nonequilibrium binding, and surface-mediated dissociation on hepatic removal of albumin-bound organic anions.Am. J. Physiol. 248:G709-G717 (1985).
R. A. Weisiger. Dissociation from albumin: A potentially rate-limiting step in the clearance substances by the liver.Proc. Natl. Acad. Sci. 82:1563–1567 (1985).
P. V. D. Sluijs, B. Postema, and K. F. Meijer. Lactosylation of albumin reduces uptake rate of dibromosulfophthalein in perfused rat liver and dissociation rate from albumin in vitro.Hepatology 7:688–695 (1987).
A. J. Levi, Z. Gatmaitan, and I. M. Arias. Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.J. Clin. Invest. 48:2156–2167 (1969).
G. Litwack, B. Ketterer, and I. M. Arias. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions.Nature 234:466–467 (1971).
W. H. Habig, M. J. Pabst, G. Fleischner. Z. Gatmaitan, I. M. Arias, and W. B. Jakoby. The identity of glutathion S-transferase B with ligandin, a major binding protein of liver.Proc. Natl. Acad. Sci. 71:3879–3882 (1974).
A. W. Wolkoff, C. A. Goresky, J. Sellin, Z. Gatmaitan, and I. M. Arias. Role of ligandin in transfer of bilirubin from plasma into liver.Am. J. Physiol. 236:638–648 (1979).
Y. Sugiyama, T. Yamada, and N. Kaplowitz. Glutathion S-transferases in elasmobranch liver.Biochem. J. 199:749–756 (1981).
Y. Sugiyama, T. Yamada, and N. Kaplowitz. Newly identified organic anion-binding proteins in rat liver cytosol.Biochim. Biophys. Acta 709:342–352 (1982).
Y. Sugiyama, T. Yamada, and N. Kaplowitz. Newly identified bile acid binders in rat liver cytosol.J. Biol. Chem. 258:3602–3607 (1983).
L. Stryer. Fluorescence spectroscopy of proteins. Fluorescent probes provide insight into the structure, interactions, and dynamics of proteins.Science 162:526–533 (1968).
B. Rabalcava, D. Martinez de Munoz, and C. Gitler, Interaction of fluorescent probes with membranes. I. Effect of ions on erythrocyte membranes.Biochemistry 8:2742–2747 (1969).
P. A. G. Fortes and J. F. Hoffman. Interactions of the fluorescent anion ANS with membrane charge in human red cell ghosts.J. Membrane Biol. 5:154–168 (1971).
S. Cheng and D. Levy. The interaction of the anionic fluorescence probe, ANS, with hepatocytes and hepatoma tissue culture cells.Biochem. Biophys. Acta 511:419–429 (1978).
T. Nakagawa, Y. Koyanagi, and H. Togawa.SALS, a Computer Program for Statistical Analysis with Least Squares Fitting. Library program of the University of Tokyo Computer Center, Tokyo, Japan, 1978.
J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. In vitro and in vivo evaluation of tissue-to-plasma partition coefficient for physiological pharmacokinetic model.J. Pharmacokin. Biopharm. 10:637–647 (1982).
W. B. Jakoby, W. H. Habig, J. H. Keen, J. N. Ketley, and M. J. Pabst.Glutathione: Metabolism and Function, Raven Press, New York, 1976, pp. 189–200.
T. Iga, M. Yokota, Y. Sugiyama, S. Awazu, and M. Hanano. Hepatic transport of indocyanine green in rats chronically intoxicated with carbon tetrachloride.Biochem. Pharmacol. 29:1291–1297 (1980).
K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.J. Pharmacokin. Biopharm. 6:165–175 (1978).
D. K. F. Meijer, A. Blom, J. G. Weitering, and R. Hornsveld. Pharmacokinetics of the hepatic transport of organic anions: Influence of extra- and intracellular binding on hepatic storage of dibromosulfophthalein and interactions with indocyanine green.J. Pharmacokin. Biopharm. 12:43–65 (1984).
S. Miyauchi, Y. Sugiyama, Y. Sawada, K. Morita, T. Iga, and M. Hanano. Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple inducator dilution method.J. Pharmacokin. Biopharm. 15:25–38 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chung, Y.B., Miyauchi, S., Sugiyama, Y. et al. Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats. Journal of Pharmacokinetics and Biopharmaceutics 18, 313–333 (1990). https://doi.org/10.1007/BF01062271
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062271